Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
우리벤처파트너스, established in 1981, is a venture capital firm located in Seoul, South Korea. The firm manages a substantial portfolio of 354 companies and has invested a total of 1,014 billion KRW as of the end of 2022. Their focus is on investment management, particularly in the healthcare and technology sectors.
Investing primarily in healthcare and technology, 우리벤처파트너스 supports companies to achieve sustainable growth. The firm is known for its active involvement with portfolio companies, aligning interests to create value. They target various stages of investment, although specific check sizes are not disclosed.
Notable companies in their portfolio include Beyond Bio, which develops anticancer drugs and Alzheimer’s treatments; CellID, focusing on immunotherapy for challenging cancers; Scatter Lab, known for the 'Ginger' app that analyzes emotional changes in couples; ASTA, which creates mass spectroscopes for disease diagnosis; and Obigo, providing HTML5-based infotainment solutions for vehicles.
To pitch 우리벤처파트너스, email your deck to webmaster@woorivp.com.
Yes, the firm often leads investment rounds in its portfolio companies, providing not just capital but also strategic support.
They are open to follow-on investments, particularly for companies that demonstrate strong growth potential and alignment with their investment thesis.
The firm manages a total amount of 1,014 billion KRW across its portfolio, although specific fund sizes are not publicly detailed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.